tiprankstipranks
Trending News
More News >

Voyageur Pharmaceuticals Secures $600K Grant to Advance Barium Contrast Products

Story Highlights
Voyageur Pharmaceuticals Secures $600K Grant to Advance Barium Contrast Products

Confident Investing Starts Here:

Voyageur Pharmaceuticals ( (TSE:VM) ) just unveiled an update.

Voyageur Pharmaceuticals has received a $600,000 grant from Alberta Innovates to support the commercialization of its Frances Creek barium sulfate, emphasizing its advantages over synthetic alternatives. The grant will assist in enhancing product quality, addressing supply shortages, and strengthening Voyageur’s market position as they prepare to launch their licensed products, which are expected to improve patient outcomes and ensure long-term shareholder value.

More about Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd. operates within the health technology industry, focusing on the development and commercialization of barium-based contrast products. The company aims to address supply shortages and enhance diagnostic imaging standards using natural resources from Canada.

YTD Price Performance: 0.0%

Average Trading Volume: 56,856

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $20.16M

For detailed information about VM stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App